Literature DB >> 15067562

[Criswick-Schepens syndrome -- familial exudative vitreoretinopathy. Report of six cases in two consanguineous families].

A Alsheikheh1, W Lieb, F Grehn.   

Abstract

BACKGROUND: Familial exudative vitreoretinopathy is a hereditary, bilaterally progressive formation of a vitreoretinal membrane. It usually occurs in full-term newborns without previous treatment with hyperbaric oxygen. In this report, we present six cases of this disease with various abnormalities of the posterior segment diagnosed in two Syrian families related by first degree of consanguinity.
DESIGN: A retrospective family analysis and presentation of cases. CASE
PRESENTATION: Six members of the two consanguineous families, aged between 3.5 and 13 years, who were systemically healthy, presented with a visual acuity ranging between light perception and 0.4 with bilateral fundus changes. The findings included: papillary, macular, and retinal temporal traction in 11 eyes, a retinal fold in 7 eyes, a fibrovascular mass in 11 eyes, vitreoretinal traction in 5 eyes, subretinal exudation in 2 eyes, pigmentary abnormalities in 2 eyes, temporal or total tractional retinal detachment in 2 eyes, and vitreous hemorrhage in 1 eye.
SUMMARY: Familial exudative vitreoretinopathy is characterized by fundus changes that resemble retinopathy of prematurity and must be differentiated from other diseases (e.g., Coats' disease, incontinentia pigmenti, persistent hyperplastic primary vitreous, and Norrie's disease).

Entities:  

Mesh:

Year:  2004        PMID: 15067562     DOI: 10.1007/s00347-004-0998-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  13 in total

1.  Signs, complications, and platelet aggregation in familial exudative vitreoretinopathy.

Authors:  C E van Nouhuys
Journal:  Am J Ophthalmol       Date:  1991-01-15       Impact factor: 5.258

2.  Familial exudative vitreoretinopathy.

Authors:  V G Criswick; C L Schepens
Journal:  Am J Ophthalmol       Date:  1969-10       Impact factor: 5.258

3.  Familial exudative vitreoretinopathy. An expanded view.

Authors:  J Gow; G L Oliver
Journal:  Arch Ophthalmol       Date:  1971-08

4.  [Exudative retinopathy with dominant transmission. Report of a new pedigree].

Authors:  H Saraux; L Laroche; F Koenig
Journal:  J Fr Ophtalmol       Date:  1985       Impact factor: 0.818

5.  Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina.

Authors:  C E van Nouhuys
Journal:  Doc Ophthalmol       Date:  1982-09-23       Impact factor: 2.379

6.  Familial exudative vitreoretinopathy.

Authors:  W E Benson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

Review 7.  Autosomal dominant vitreoretinochoroidopathy. Report of the third family.

Authors:  E I Traboulsi; J W Payne
Journal:  Arch Ophthalmol       Date:  1993-02

8.  Autosomal dominant exudative vitreoretinopathy.

Authors:  R R Ober; A C Bird; A M Hamilton; K Sehmi
Journal:  Br J Ophthalmol       Date:  1980-02       Impact factor: 4.638

9.  A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy.

Authors:  Z Y Chen; E M Battinelli; A Fielder; S Bundey; K Sims; X O Breakefield; I W Craig
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

10.  [No disorder of arachidonic acid-induced thrombocyte aggregation in familial exudative vitreoretinopathy].

Authors:  S Bopp; T Wagner; H Laqua
Journal:  Klin Monbl Augenheilkd       Date:  1989-01       Impact factor: 0.700

View more
  2 in total

1.  [Familial exudative vitreoretinopathy].

Authors:  D Finis; J Stammen; A M Joussen
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

2.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.